News

Abbott announced the FDA approved its transcatheter mitral valve replacement system for patients with severe mitral annular ...
The system is available for patients whose mitral valves are not working properly due to severe mitral annular calcification.
The Tendyne system is designated for those who are at high risk for traditional open-heart surgery. It helps with those with ...
Abbott Laboratories (NYSE:ABT) has received FDA approval today for its Tendyne™ transcatheter mitral valve replacement (TMVR) ...
Abbott has scored FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR) system, giving fresh hope to ...